Current estimates indicate that more than 70% of new chemical entities require solubilization technology to achieve efficacious plasma exposure. Amorphous solid dispersion technology is a leading approach to improve solubility and dissolution rate of these insoluble compounds by providing a supersaturated concentration of drug in the gastrointestinal environment which often translates to rapid absorption and improved bioavailability.
Bend Research, a division of Capsugel Dosage Form Solutions, will present a webinar that will emphasize the fundamentals of formulating and processing of spray-dried dispersions, including stability assessment, in-vitro performance, and downstream manufacturability.
In this webinar we will show:
Speakers for this webinar are:
See the webinar here: